Humaneva Group Secures Major US Private Equity Investment to Accelerate Global Clinical Research Market Expansion
Humaneva Inc. has entered into a significant investment agreement with Viking Global Investors, a global investment firm based in the United States (“Viking”). Under this agreement, Viking acquired a minority stake in Humaneva Inc., a spin-off of NEUCA S.A, for $50M. In addition, Viking has been granted a one-year option to invest an additional $50M […]